Skip to main content

Advertisement

Table 4 Time to management decision for patients with EBUS as the only invasive investigation compared to patients with EBUS combined with other invasive investigations (Post-EBUS cohort N = 84a)

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

  Single EBUS-GS only (n = 14) median (IQR) EBUS-GS plus other invasive investigations (n = 14)bmedian (IQR) pc Single EBUS-TBNA only (n = 28) median (IQR) EBUS-TBNA plus other invasive investigations (n = 28) median (IQR) pc
Time to management decision (days) 10 (28) 45 (48) 0.001* 10 (10.0) 26.5 (29) <0.001*
  1. *p < 0.01
  2. aexcludes 6 patients with both EBUS-GS and EBUS-TBNA
  3. bincludes 1 patient with 2 EBUS-GS investigations
  4. cMann–Whitney U test